US2013224797A1PendingUtilityA1
Method for producing glycoprotein having mannose residue as non-reducing end of sugar chain
Est. expiryOct 15, 2030(~4.3 yrs left)· nominal 20-yr term from priority
Inventors:Kenichi Takahashi
C12Y 302/01096C12P 21/005C12Y 302/01052C12N 9/2402C12N 5/10C12P 21/02C12N 15/52
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed is a method for producing a glycoprotein using mammalian cells, wherein all or part of the non-reducing ends of N-glycoside binding sugar chains are mannose residues. The method is a method for producing glycoproteins using transformant mammalian cells which are prepared by introducing thereinto a β-N-acetylglucosaminidase gene and inducing its expression.
Claims
exact text as granted — not AI-modified1 . A transformant mammalian cell having an exogenous β-N-acetylglucosaminidase gene introduced and allowed to express itself therein.
2 . The transformant mammalian cell according to claim 1 , wherein β-N-acetylglucosaminidase expressed following introduction of the β-N-acetylglucosaminidase gene exhibits the activity thereof in Golgi bodies.
3 . The transformant mammalian cell according to claim 1 , wherein the β-N-acetylglucosaminidase gene is of insect origin.
4 . The transformant mammalian cell according to claim 3 , wherein the insect is an insect of Lepidoptera.
5 . The transformant mammalian cell according to claim 4 , wherein the insect of Lepidoptera is Spodoptera frugiperda or Bombyx mori.
6 . The transformant mammalian cell according to claim 5 , wherein the β-N-acetylglucosaminidase gene is one or more genes selected from the group consisting of β -N-acetylglucosaminidase 1 gene, β-N-acetylglucosaminidase 3 gene, SfFDL gene, and BmFDL gene.
7 . The transformant mammalian cell according to claim 1 having an exogenous gene encoding a predetermined glycoprotein further introduced and allowed to express itself so as to produced the predetermined glycoprotein.
8 . The transformant mammalian cell according to claim 7 , wherein the exogenous gene encoding the predetermined glycoprotein is a gene of human origin.
9 . The transformant mammalian cell according to claim 8 , wherein the gene of human origin is a gene encoding a lysosomal enzyme.
10 . The transformant mammalian cell according to claim 9 , wherein the lysosomal enzyme is selected from the group consisting of glucocerebrosidase, acid sphingomyelinase, lysosomal acid lipase, acid a-glucosidase, N-acetylgalactosamine-4-sulfatase, iduronate-2-sulfatase, α-L-iduronidase, α-galactosidase A, hexosaminidase, α-N-acetylgalactosaminidase, α-mannosidase, and sialidase.
11 . The transformant mammalian cell according to claim 9 , wherein the lysosomal enzyme is glucocerebrosidase.
12 . A method for production of a glycoprotein having N-glycosidic bond-linked sugar chains, wherein all or part of the non-reducing ends of the sugar chains comprise mannose residues, wherein the method comprises the steps of:
(a) culturing the mammalian cell according to claim 1 in a medium to allow the glycoprotein be expressed, and (b) purifying the glycoprotein expressed in (a) above.
13 . The method of claim 12 , wherein the mammalian cell employed has an exogenous gene encoding a predetermined glycoprotein further introduced and allowed to express itself so as to produce the predetermined glycoprotein.
14 . The method for production according to claim 13 , wherein the exogenous gene encoding the glycoprotein is a gene of human origin.
15 . The method for production according to claim 14 , wherein the gene of human origin is a gene encoding a lysosomal enzyme.
16 . The method for production according to claim 15 , wherein the lysosomal enzyme is selected from the group consisting of glucocerebrosidase, acid sphingomyelinase, lysosomal acid lipase, acid α-glucosidase, N-acetylgalactosamine-4-sulfatase, iduronate-2-sulfatase, α-L-iduronidase, α-galactosidase A, hexosaminidase, α-N-acetylgalactosaminidase, α-mannosidase, and sialidase.
17 . The method for production according to claim 15 , wherein the lysosomal enzyme is glucocerebrosidase.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.